2m 2m 2m 2m 2m 2m 2m
ARVINAS (ARVN)
NASDAQ
$7.95-$0.15 (-1.84%)
Price as of Jul 14, 2026 4:12 AM EDT- $533.6MMarket Cap
- 2.92%1-Year Change
- BiotechnologyIndustry
ARVINAS (ARVN)
$7.95-$0.15 (-1.84%)
ARVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.10 | ||
Change | -$0.17 (-2.06%) | ||
Open | $8.24 | ||
High | $8.24 | ||
Low | $7.95 | ||
Previous Close | $8.27 | ||
Volume | 678,270 | ||
30-Day Average Volume | 796,509 | ||
1-Week Change | -4.14% | ||
1-Month Change | 6.86% | ||
1-Year Change | 2.92% | ||
3-Year Change | -67.11% | ||
5-Year Change | -89.92% | ||
Fundamentals | |||
Shares Outstanding | 64.5M | ||
Total Assets | $647.5M | ||
Market Cap | $533.6M | ||
Enterprise Value | $446.8M | ||
Period: QTR TTM FY | |||
Revenue | $15.6M | ||
Net Income | -$57.6M | ||
Free Cash Flow | -$70.5M | ||
EBIT | -$57.5M | ||
EBITDA | -$56.8M | ||
Net Working Capital | $514.8M | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 29 | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | -1 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue